These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6549773

  • 1. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM, Tankersley DL, Mason BL.
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [Abstract] [Full Text] [Related]

  • 2. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH, Bouma BN, Schalekamp MA.
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [Abstract] [Full Text] [Related]

  • 3. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ, Dooijewaard G, Turion PN.
    Thromb Haemost; 1991 Feb 12; 65(2):144-8. PubMed ID: 1905069
    [Abstract] [Full Text] [Related]

  • 4. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI.
    J Clin Invest; 1979 Oct 12; 64(4):1056-65. PubMed ID: 479368
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T, Ohno Y, Shimada T, Kato H, Iwanaga S.
    Adv Exp Med Biol; 1983 Oct 12; 156():87-107. PubMed ID: 6602465
    [Abstract] [Full Text] [Related]

  • 6. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP, Gozin D.
    Thromb Haemost; 1979 Aug 31; 42(2):538-47. PubMed ID: 505362
    [Abstract] [Full Text] [Related]

  • 7. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD, Cochrane CG, Griffin JH.
    J Clin Invest; 1977 Jun 31; 59(6):1167-75. PubMed ID: 864009
    [Abstract] [Full Text] [Related]

  • 8. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA.
    Thromb Haemost; 1999 Sep 31; 82(3):1033-40. PubMed ID: 10494760
    [Abstract] [Full Text] [Related]

  • 9. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD, Rosenfeld R, Schiffman S.
    J Lab Clin Med; 1988 Nov 31; 112(5):560-6. PubMed ID: 3263454
    [Abstract] [Full Text] [Related]

  • 10. [Determination of plasma prekallikrein using beta-XIIa (Hageman factor fragment)].
    Komiyama Y, Egawa H, Murata K.
    Rinsho Byori; 1984 May 31; 32(5):558-62. PubMed ID: 6332927
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW.
    Thromb Haemost; 1991 Nov 01; 66(5):540-7. PubMed ID: 1725067
    [Abstract] [Full Text] [Related]

  • 13. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
    Gallimore MJ.
    Scand J Clin Lab Invest Suppl; 1985 Nov 01; 178():127-32. PubMed ID: 3867113
    [Abstract] [Full Text] [Related]

  • 14. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F, Keus FJ, Vlooswijk RA, Bouma BN.
    Blood; 1982 Jun 01; 59(6):1225-33. PubMed ID: 6177360
    [Abstract] [Full Text] [Related]

  • 15. Contact activation of human plasma prorenin in vitro.
    Blumberg AL, Sealey JE, Atlas SA, Laragh JH, Dharmgrongartama B, Kaplan AP.
    J Lab Clin Med; 1981 Jun 01; 97(6):771-8. PubMed ID: 7014741
    [Abstract] [Full Text] [Related]

  • 16. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA, Sculley PW, Green EM, Johnson GS.
    Am J Vet Res; 1986 Nov 01; 47(11):2464-7. PubMed ID: 3641551
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF, Silver LD, Schapira M, Colman RW.
    J Clin Invest; 1984 Apr 01; 73(4):954-62. PubMed ID: 6561202
    [Abstract] [Full Text] [Related]

  • 19. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F, Ratnoff OD.
    J Lab Clin Med; 1983 Oct 01; 102(4):487-99. PubMed ID: 6604770
    [Abstract] [Full Text] [Related]

  • 20. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
    Lämmle B, Berrettini M, Griffin JH.
    Semin Thromb Hemost; 1987 Jan 01; 13(1):106-14. PubMed ID: 3494310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.